185 related articles for article (PubMed ID: 35768667)
1. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
Toyoda J; Sahara K; Maithel SK; Abbott DE; Poultsides GA; Wolfgang C; Fields RC; He J; Scoggins C; Idrees K; Shen P; Endo I; Pawlik TM
Ann Surg Oncol; 2022 Nov; 29(12):7605-7614. PubMed ID: 35768667
[TBL] [Abstract][Full Text] [Related]
2. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
4. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis.
Tsilimigras DI; Moris D; Mehta R; Paredes AZ; Sahara K; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
HPB (Oxford); 2020 Dec; 22(12):1667-1674. PubMed ID: 32265108
[TBL] [Abstract][Full Text] [Related]
5. Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Woldesenbet S; Araujo Lima H; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
World J Surg; 2023 Jul; 47(7):1792-1800. PubMed ID: 37010541
[TBL] [Abstract][Full Text] [Related]
6. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
7. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
Krasnick BA; Jin LX; Davidson JT; Sanford DE; Ethun CG; Pawlik TM; Poultsides GA; Tran T; Idrees K; Hawkins WG; Chapman WC; Doyle MBM; Weber SM; Strasberg SM; Salem A; Martin RCG; Isom CA; Scoggins C; Schmidt CR; Shen P; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
J Surg Oncol; 2018 Mar; 117(3):363-371. PubMed ID: 29284072
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
11. ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
Toyoda J; Sahara K; Endo I; Pawlik TM
Ann Surg Oncol; 2022 Nov; 29(12):7615-7616. PubMed ID: 35776259
[No Abstract] [Full Text] [Related]
12. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
13. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
[TBL] [Abstract][Full Text] [Related]
14. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification for overall survival and recurrence-free survival after R0 resection for solitary intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Eur J Radiol; 2023 Dec; 169():111190. PubMed ID: 37979460
[TBL] [Abstract][Full Text] [Related]
16. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.
Fu J; Chen Q; Lai Z; Lin K; Fang G; Ding Z; Gao Y; Zeng Y
BMC Cancer; 2023 Feb; 23(1):188. PubMed ID: 36829168
[TBL] [Abstract][Full Text] [Related]
17. Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis.
Ding L; Wang X; Deng X; Xia W; Wang K; Yu X; Huang Y; Wang J
Cancer Med; 2023 Mar; 12(6):7019-7028. PubMed ID: 36479836
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.
Spolverato G; Yakoob MY; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
Ann Surg Oncol; 2015 Nov; 22(12):4020-8. PubMed ID: 25762481
[TBL] [Abstract][Full Text] [Related]
19. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
